Genmab A/S (GMAB)

29.29 +0.39 (+1.35%) USD  |  NASDAQ  |  Feb 20, 16:00
28.45 -0.84 (-2.87%) Pre-Market: 08:38
More

Genmab Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for GMAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Novo Nordisk A/S Upgrade
Ascendis Pharma A/S Upgrade
Zealand Pharma A/S Upgrade